Skip to main content

Day: March 25, 2025

The Children’s Place to Release Fourth Quarter and Year-End Fiscal 2024 Financial Results and Letter to Shareholders

SECAUCUS, N.J., March 25, 2025 (GLOBE NEWSWIRE) — The Children’s Place, Inc. (Nasdaq: PLCE), the largest pure-play children’s specialty retailer in North America with an omni-channel portfolio of brands and an industry-leading digital-first model, today announced that their fourth quarter and year-end fiscal 2024 financial results, and Turki S. AlRajhi’s annual letter to shareholders, will be released on Friday, April 11, 2025 at approximately 4:30 p.m. Eastern Time where it can be accessed at https://corporate.childrensplace.com/. About The Children’s Place The Children’s Place is the largest pure-play children’s specialty retailer in North America with an omni-channel portfolio of brands and an industry-leading digital-first model. Its global retail and wholesale network includes two digital storefronts, more than 500 stores...

Continue reading

Gevo Announces Rescheduled Fourth Quarter 2024 Earnings Release and Conference Call

ENGLEWOOD, Colo., March 25, 2025 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) announced today that it will host its rescheduled conference call on March 27, 2025, at 4:30 p.m. ET (2:30 p.m. MT) to report its financial results for the fourth quarter ended December 31, 2024. To participate in the live call, please register through the following event weblink:   https://register.vevent.com/register/BIfe02700a31384d12946e60bf35964cb8  After registering, participants will be provided with a dial-in number and pin. To listen to the conference call (audio only), please register through the following event weblink:   https://edge.media-server.com/mmc/p/h9wkbjf5  A webcast replay will be available two hours after the conference call ends on March 27, 2025. The archived webcast will be available in the Investor Relations section of Gevo’s...

Continue reading

Atossa Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update

Ended 2024 with $71.1 million of cash and cash equivalents and no debt Conference Call and Webcast Scheduled for Tuesday, March 25, 2025, at 8:30 a.m. Eastern Time SEATTLE, March 25, 2025 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced its financial results for the full year ended December 31, 2024 and provided an update on recent company developments. Fourth Quarter and Early 2025 HighlightsStrategic Decision to Pursue Metastatic Breast Cancer Indication: Atossa plans to advance its lead program, (Z)-endoxifen, to target metastatic breast cancer. The Company believes this approach may offer a more streamlined regulatory pathway to deliver (Z)-endoxifen to patients with urgent...

Continue reading

Addition Financial Credit Union and Envision Credit Union Submit Merger Application to Regulators

Kevin Miller and Darryl Worrell PHOTO(left to right) Kevin Miller, President and CEO of Addition Financial Credit Union; Darryl Worrell, President and CEO of Envision Credit UnionLAKE MARY, Fla. and TALLAHASSEE, Fla., March 25, 2025 (GLOBE NEWSWIRE) — Addition Financial Credit Union and Envision Credit Union are pleased to announce they have submitted their merger application to the National Credit Union Administration (NCUA) and Florida’s Office of Financial Regulation (OFR). This marks a significant step forward in the planned merger of these two award-winning institutions, which aims to expand service to members across Central Florida, North Florida, and South Georgia. Under the terms of the agreement, the combined credit union will continue to operate as Addition Financial Credit Union under the leadership of current...

Continue reading

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

‒ Q4 2024 Net Revenue of $31.2mm; 2024 Net Revenue of $43.5mm ‒ ‒ Q4 Net Income of $13.5mm and Adjusted EBITDA of $15.3mm ‒ ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time ‒ BERKELEY HEIGHTS, N.J., March 25, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced financial results for the fourth quarter and full year ended December 31, 2024 and provided an update on its business. Recent Corporate Highlights:CorMedix today reports its second full quarter of DefenCath sales since commencing outpatient launch in July 2024 and first partial year of DefenCath sales. The Company reported net sales of $31.2 million for the fourth quarter and $43.5 million for full year...

Continue reading

Competition Authority approved new water prices to be applied by Tallinna Vesi

The Competition Authority approved the new price for water services in the Tallinn and Saue area at €2.10 per cubic metre for private customers and €3.33 per cubic metre for business customers, excluding VAT. The price change is due to the need to harmonize the price of water for private and business customers, as required by law, and the need for investment to improve the sustainability of the water infrastructure. According to the CEO of Tallinna Vesi, Aleksandr Timofejev, the price for water services for private customers in Tallinn and Harjumaa will remain one of the lowest in Estonia. “It is important for us to provide sustainable water services at prices that our customers can afford. While the average household in Estonia spends more than 1% of its household income on water services, the average water bill in Tallinna Vesi’s...

Continue reading

Super Hi Reports Unaudited Financial Results for the Fourth Quarter and Full Year 2024

SINGAPORE, March 25, 2025 (GLOBE NEWSWIRE) — Super Hi International Holding Ltd. (NASDAQ: HDL and HKEX: 9658) (“Super Hi” or the “Company”), a leading Chinese cuisine restaurant brand operating Haidilao hot pot restaurants in the international market, today announced its unaudited financial results for the three months (“Fourth Quarter 2024”) and the full year ended December 31, 2024 (“Full Year 2024”). Fourth Quarter 2024 HighlightsRevenue was US$208.8 million, representing an increase of 10.4% from US$189.2 million in the same period of 2023. In the fourth quarter of 2024, the Company opened 2 restaurants and simultaneously closed 1 restaurant to improve the restaurant configuration. The total number of Haidilao restaurants as of December 31, 2024 was 122, reflecting a net increase of 7 since December 31, 2023. Total table...

Continue reading

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

GUANGZHOU, China, March 25, 2025 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported unaudited financial results for the three months and the year ended December 31, 2024. 2024 Business Overview and Recent UpdatesCorporate UpdatesCompleted profitability-driven organizational optimization, execution towards profitability well underwayEarly Detection  THUNDER study for 6-cancer test was included in the Diagnosis and Treatment Guidelines for Primary Liver Cancer (2024 Edition) and the Expert Consensus on Detection and Clinical Application of Tumor DNA Methylation Markers (2024 Edition), showing an impressive performance of ELSA-seq using cfDNA in...

Continue reading

Descartes Acquires 3GTMS

Strengthens Transportation Management Capabilities for Shippers and Logistics Services Providers WATERLOO, Ontario and ATLANTA, March 25, 2025 (GLOBE NEWSWIRE) — Descartes Systems Group (TSX: DSG) (Nasdaq: DSGX), the global leader in uniting logistics-intensive businesses in commerce, announced that it has acquired 3GTMS (3G), a leading provider of transportation management solutions. Based in the US, 3G’s transportation management solutions combine modern cloud architecture, an expansive carrier network, and planning-driven automation to help customers improve costs, customer satisfaction, and efficiency. Shippers, third-party logistics providers and freight brokers leverage 3G’s platform to optimize domestic over-the-road shipments with tools for planning, rating, consolidation, and routing that cover the entire shipment lifecycle. “3G’s...

Continue reading

O-I Glass Pioneers Sustainable Glassmaking with Successful Biofuel Trial

Achieved significant reduction in greenhouse gas emissions using 100% biofuel Successfully demonstrated the technical viability of using biofuel at scale Trial was part of the UK government’s “Net Zero Innovation Portfolio” program PERRYSBURG, Ohio /HARLOW, United Kingdom,, March 25, 2025 (GLOBE NEWSWIRE) — — O-I Glass, Inc. (“O-I Glass” or “O-I”) has recently successfully completed a groundbreaking trial in its plant in Harlow, UK, using 100% biofuel to replace natural gas in the furnace for the glass-making process. This achievement is part of a larger initiative led by Glass Futures, a UK-based glass R&D organization, and part of the UK government’s “Net Zero Innovation Portfolio” program, aimed at exploring sustainable fuel options for the industry in the UK. Key Highlights:Significant Reduction...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.